nodes	percent_of_prediction	percent_of_DWPC	metapath
Maprotiline—ABCB1—adrenal gland cancer	0.814	1	CbGaD
Maprotiline—SLC6A2—sympathetic nervous system—adrenal gland cancer	0.0126	0.164	CbGeAlD
Maprotiline—HTR7—sympathetic nervous system—adrenal gland cancer	0.0122	0.158	CbGeAlD
Maprotiline—HTR7—vein—adrenal gland cancer	0.0114	0.148	CbGeAlD
Maprotiline—HTR2A—sympathetic nervous system—adrenal gland cancer	0.00758	0.0985	CbGeAlD
Maprotiline—HTR2A—vein—adrenal gland cancer	0.00709	0.0922	CbGeAlD
Maprotiline—CYP1A2—urine—adrenal gland cancer	0.00531	0.069	CbGeAlD
Maprotiline—HTR2A—urine—adrenal gland cancer	0.00415	0.054	CbGeAlD
Maprotiline—CYP2D6—urine—adrenal gland cancer	0.00378	0.0492	CbGeAlD
Maprotiline—Sertraline—ABCB1—adrenal gland cancer	0.00262	0.524	CrCbGaD
Maprotiline—SLC6A2—gonad—adrenal gland cancer	0.00152	0.0197	CbGeAlD
Maprotiline—Protriptyline—ABCB1—adrenal gland cancer	0.00151	0.301	CrCbGaD
Maprotiline—HTR7—gonad—adrenal gland cancer	0.00146	0.019	CbGeAlD
Maprotiline—DRD2—pituitary gland—adrenal gland cancer	0.00135	0.0175	CbGeAlD
Maprotiline—SLC6A2—adrenal gland—adrenal gland cancer	0.00132	0.0172	CbGeAlD
Maprotiline—HTR7—adrenal gland—adrenal gland cancer	0.00127	0.0165	CbGeAlD
Maprotiline—HRH1—adrenal gland—adrenal gland cancer	0.000951	0.0124	CbGeAlD
Maprotiline—HTR2A—gonad—adrenal gland cancer	0.000911	0.0118	CbGeAlD
Maprotiline—HTR2A—pituitary gland—adrenal gland cancer	0.000889	0.0116	CbGeAlD
Maprotiline—HTR2A—adrenal gland—adrenal gland cancer	0.000794	0.0103	CbGeAlD
Maprotiline—ABCB1—adrenal cortex—adrenal gland cancer	0.000721	0.00937	CbGeAlD
Maprotiline—ABCB1—gonad—adrenal gland cancer	0.000597	0.00776	CbGeAlD
Maprotiline—ABCB1—pituitary gland—adrenal gland cancer	0.000582	0.00757	CbGeAlD
Maprotiline—ABCB1—adrenal gland—adrenal gland cancer	0.00052	0.00676	CbGeAlD
Maprotiline—Desipramine—ABCB1—adrenal gland cancer	0.000475	0.0949	CrCbGaD
Maprotiline—Imipramine—ABCB1—adrenal gland cancer	0.000403	0.0805	CrCbGaD
Maprotiline—HTR2C—GPCR downstream signaling—GNAS—adrenal gland cancer	6.88e-05	0.000661	CbGpPWpGaD
Maprotiline—DRD2—Signaling by GPCR—PRKACA—adrenal gland cancer	6.8e-05	0.000654	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—SDHB—adrenal gland cancer	6.77e-05	0.000651	CbGpPWpGaD
Maprotiline—HTR2A—Signaling by GPCR—PRKACA—adrenal gland cancer	6.69e-05	0.000643	CbGpPWpGaD
Maprotiline—HRH1—Signaling by GPCR—PRKACA—adrenal gland cancer	6.68e-05	0.000642	CbGpPWpGaD
Maprotiline—CHRM1—Signaling by GPCR—PRKACA—adrenal gland cancer	6.66e-05	0.00064	CbGpPWpGaD
Maprotiline—CHRM3—Signaling by GPCR—PRKACA—adrenal gland cancer	6.64e-05	0.000638	CbGpPWpGaD
Maprotiline—CHRM2—Signaling by GPCR—PRKACA—adrenal gland cancer	6.57e-05	0.000631	CbGpPWpGaD
Maprotiline—HTR2C—Signaling by GPCR—CDC42—adrenal gland cancer	6.54e-05	0.000628	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—SPRY2—adrenal gland cancer	6.51e-05	0.000626	CbGpPWpGaD
Maprotiline—DRD2—Circadian rythm related genes—TP53—adrenal gland cancer	6.43e-05	0.000618	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—MED12—adrenal gland cancer	6.43e-05	0.000617	CbGpPWpGaD
Maprotiline—DRD2—GPCR downstream signaling—CDC42—adrenal gland cancer	6.35e-05	0.00061	CbGpPWpGaD
Maprotiline—ABCB1—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	6.35e-05	0.00061	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—TSHR—adrenal gland cancer	6.34e-05	0.00061	CbGpPWpGaD
Maprotiline—CHRM1—Circadian rythm related genes—TP53—adrenal gland cancer	6.29e-05	0.000604	CbGpPWpGaD
Maprotiline—HTR7—GPCR downstream signaling—POMC—adrenal gland cancer	6.28e-05	0.000604	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—GNRH1—adrenal gland cancer	6.28e-05	0.000604	CbGpPWpGaD
Maprotiline—HTR2A—GPCR downstream signaling—CDC42—adrenal gland cancer	6.25e-05	0.000601	CbGpPWpGaD
Maprotiline—HTR2C—Signaling by GPCR—GNAS—adrenal gland cancer	6.25e-05	0.0006	CbGpPWpGaD
Maprotiline—HRH1—GPCR downstream signaling—CDC42—adrenal gland cancer	6.24e-05	0.000599	CbGpPWpGaD
Maprotiline—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—adrenal gland cancer	6.23e-05	0.000599	CbGpPWpGaD
Maprotiline—CHRM1—GPCR downstream signaling—CDC42—adrenal gland cancer	6.22e-05	0.000597	CbGpPWpGaD
Maprotiline—CHRM3—GPCR downstream signaling—CDC42—adrenal gland cancer	6.2e-05	0.000596	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—GNRH1—adrenal gland cancer	6.18e-05	0.000594	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—PRKACA—adrenal gland cancer	6.18e-05	0.000593	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—GNRH1—adrenal gland cancer	6.17e-05	0.000593	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—GNRH1—adrenal gland cancer	6.15e-05	0.000591	CbGpPWpGaD
Maprotiline—CHRM2—GPCR downstream signaling—CDC42—adrenal gland cancer	6.14e-05	0.00059	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—GNRH1—adrenal gland cancer	6.13e-05	0.000589	CbGpPWpGaD
Maprotiline—DRD2—GPCR downstream signaling—GNAS—adrenal gland cancer	6.07e-05	0.000583	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—GNRH1—adrenal gland cancer	6.07e-05	0.000583	CbGpPWpGaD
Maprotiline—HTR2A—GPCR downstream signaling—GNAS—adrenal gland cancer	5.97e-05	0.000574	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—MEN1—adrenal gland cancer	5.96e-05	0.000573	CbGpPWpGaD
Maprotiline—HRH1—GPCR downstream signaling—GNAS—adrenal gland cancer	5.96e-05	0.000573	CbGpPWpGaD
Maprotiline—CHRM1—GPCR downstream signaling—GNAS—adrenal gland cancer	5.94e-05	0.000571	CbGpPWpGaD
Maprotiline—CHRM4—GPCR downstream signaling—POMC—adrenal gland cancer	5.93e-05	0.00057	CbGpPWpGaD
Maprotiline—CHRM3—GPCR downstream signaling—GNAS—adrenal gland cancer	5.92e-05	0.000569	CbGpPWpGaD
Maprotiline—CHRM2—GPCR downstream signaling—GNAS—adrenal gland cancer	5.86e-05	0.000564	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—PRKACA—adrenal gland cancer	5.83e-05	0.00056	CbGpPWpGaD
Maprotiline—DRD2—Signaling by GPCR—CDC42—adrenal gland cancer	5.77e-05	0.000554	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—SPRY2—adrenal gland cancer	5.74e-05	0.000552	CbGpPWpGaD
Maprotiline—HTR7—Signaling by GPCR—POMC—adrenal gland cancer	5.7e-05	0.000548	CbGpPWpGaD
Maprotiline—CHRM5—GPCR downstream signaling—POMC—adrenal gland cancer	5.68e-05	0.000546	CbGpPWpGaD
Maprotiline—HTR2A—Signaling by GPCR—CDC42—adrenal gland cancer	5.68e-05	0.000545	CbGpPWpGaD
Maprotiline—HRH1—Signaling by GPCR—CDC42—adrenal gland cancer	5.66e-05	0.000544	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—SPRY2—adrenal gland cancer	5.65e-05	0.000543	CbGpPWpGaD
Maprotiline—CHRM1—Signaling by GPCR—CDC42—adrenal gland cancer	5.65e-05	0.000543	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—SPRY2—adrenal gland cancer	5.64e-05	0.000542	CbGpPWpGaD
Maprotiline—CHRM3—Signaling by GPCR—CDC42—adrenal gland cancer	5.63e-05	0.000541	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—SPRY2—adrenal gland cancer	5.62e-05	0.00054	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—SPRY2—adrenal gland cancer	5.6e-05	0.000539	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—TSHR—adrenal gland cancer	5.6e-05	0.000538	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—PRKACA—adrenal gland cancer	5.58e-05	0.000537	CbGpPWpGaD
Maprotiline—CHRM2—Signaling by GPCR—CDC42—adrenal gland cancer	5.57e-05	0.000536	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—SPRY2—adrenal gland cancer	5.55e-05	0.000533	CbGpPWpGaD
Maprotiline—DRD2—Signaling by GPCR—GNAS—adrenal gland cancer	5.51e-05	0.00053	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—TSHR—adrenal gland cancer	5.51e-05	0.000529	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—TSHR—adrenal gland cancer	5.5e-05	0.000528	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—TSHR—adrenal gland cancer	5.48e-05	0.000526	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—SDHD—adrenal gland cancer	5.47e-05	0.000525	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—RRM1—adrenal gland cancer	5.47e-05	0.000525	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—TSHR—adrenal gland cancer	5.46e-05	0.000525	CbGpPWpGaD
Maprotiline—HTR2A—Signaling by GPCR—GNAS—adrenal gland cancer	5.42e-05	0.000521	CbGpPWpGaD
Maprotiline—HRH1—Signaling by GPCR—GNAS—adrenal gland cancer	5.41e-05	0.00052	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—TSHR—adrenal gland cancer	5.41e-05	0.00052	CbGpPWpGaD
Maprotiline—CHRM1—Signaling by GPCR—GNAS—adrenal gland cancer	5.4e-05	0.000518	CbGpPWpGaD
Maprotiline—CHRM4—Signaling by GPCR—POMC—adrenal gland cancer	5.39e-05	0.000518	CbGpPWpGaD
Maprotiline—CHRM3—Signaling by GPCR—GNAS—adrenal gland cancer	5.38e-05	0.000517	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	5.33e-05	0.000512	CbGpPWpGaD
Maprotiline—CHRM2—Signaling by GPCR—GNAS—adrenal gland cancer	5.33e-05	0.000512	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—MEN1—adrenal gland cancer	5.26e-05	0.000506	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—CDC42—adrenal gland cancer	5.24e-05	0.000503	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—MEN1—adrenal gland cancer	5.18e-05	0.000498	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—MEN1—adrenal gland cancer	5.17e-05	0.000497	CbGpPWpGaD
Maprotiline—CHRM5—Signaling by GPCR—POMC—adrenal gland cancer	5.16e-05	0.000496	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—RRM1—adrenal gland cancer	5.15e-05	0.000495	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—SDHD—adrenal gland cancer	5.15e-05	0.000495	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—MEN1—adrenal gland cancer	5.15e-05	0.000495	CbGpPWpGaD
Maprotiline—ABCB1—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	5.15e-05	0.000495	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—MEN1—adrenal gland cancer	5.14e-05	0.000493	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—MEN1—adrenal gland cancer	5.09e-05	0.000489	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—IGF2—adrenal gland cancer	5.05e-05	0.000485	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—GNAS—adrenal gland cancer	5.01e-05	0.000481	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—CDC42—adrenal gland cancer	4.95e-05	0.000475	CbGpPWpGaD
Maprotiline—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—adrenal gland cancer	4.94e-05	0.000474	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—IGF1R—adrenal gland cancer	4.88e-05	0.000469	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—IGF2—adrenal gland cancer	4.77e-05	0.000458	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—CDC42—adrenal gland cancer	4.74e-05	0.000455	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—GNAS—adrenal gland cancer	4.73e-05	0.000454	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—PRKACA—adrenal gland cancer	4.69e-05	0.00045	CbGpPWpGaD
Maprotiline—HTR2C—GPCR downstream signaling—POMC—adrenal gland cancer	4.63e-05	0.000445	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—IGF1R—adrenal gland cancer	4.61e-05	0.000443	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—IGF2—adrenal gland cancer	4.57e-05	0.000439	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—PRKACA—adrenal gland cancer	4.55e-05	0.000437	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—GNAS—adrenal gland cancer	4.53e-05	0.000435	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—IGF1R—adrenal gland cancer	4.41e-05	0.000424	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—SDHD—adrenal gland cancer	4.37e-05	0.00042	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—RRM1—adrenal gland cancer	4.37e-05	0.00042	CbGpPWpGaD
Maprotiline—HTR2C—Signaling by GPCR—POMC—adrenal gland cancer	4.21e-05	0.000404	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—TERT—adrenal gland cancer	4.2e-05	0.000404	CbGpPWpGaD
Maprotiline—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—adrenal gland cancer	4.14e-05	0.000398	CbGpPWpGaD
Maprotiline—DRD2—GPCR downstream signaling—POMC—adrenal gland cancer	4.09e-05	0.000393	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—MED12—adrenal gland cancer	4.08e-05	0.000392	CbGpPWpGaD
Maprotiline—HTR2A—GPCR downstream signaling—POMC—adrenal gland cancer	4.02e-05	0.000386	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—PRKACA—adrenal gland cancer	4.02e-05	0.000386	CbGpPWpGaD
Maprotiline—HRH1—GPCR downstream signaling—POMC—adrenal gland cancer	4.01e-05	0.000386	CbGpPWpGaD
Maprotiline—CHRM1—GPCR downstream signaling—POMC—adrenal gland cancer	4e-05	0.000384	CbGpPWpGaD
Maprotiline—CHRM3—GPCR downstream signaling—POMC—adrenal gland cancer	3.99e-05	0.000383	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—TERT—adrenal gland cancer	3.97e-05	0.000381	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—PRKACA—adrenal gland cancer	3.95e-05	0.00038	CbGpPWpGaD
Maprotiline—CHRM2—GPCR downstream signaling—POMC—adrenal gland cancer	3.95e-05	0.000379	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—PRKACA—adrenal gland cancer	3.95e-05	0.000379	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—PRKACA—adrenal gland cancer	3.93e-05	0.000378	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—PRKACA—adrenal gland cancer	3.92e-05	0.000377	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—PRKACA—adrenal gland cancer	3.88e-05	0.000373	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—CDC42—adrenal gland cancer	3.86e-05	0.000371	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—MED12—adrenal gland cancer	3.84e-05	0.000369	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—TERT—adrenal gland cancer	3.8e-05	0.000365	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—GNAS—adrenal gland cancer	3.8e-05	0.000365	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—ABCB1—adrenal gland cancer	3.73e-05	0.000358	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—IGF2—adrenal gland cancer	3.72e-05	0.000358	CbGpPWpGaD
Maprotiline—DRD2—Signaling by GPCR—POMC—adrenal gland cancer	3.71e-05	0.000357	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—GNAS—adrenal gland cancer	3.69e-05	0.000355	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—BAD—adrenal gland cancer	3.66e-05	0.000351	CbGpPWpGaD
Maprotiline—HTR2A—Signaling by GPCR—POMC—adrenal gland cancer	3.65e-05	0.000351	CbGpPWpGaD
Maprotiline—HRH1—Signaling by GPCR—POMC—adrenal gland cancer	3.64e-05	0.00035	CbGpPWpGaD
Maprotiline—CHRM1—Signaling by GPCR—POMC—adrenal gland cancer	3.63e-05	0.000349	CbGpPWpGaD
Maprotiline—CHRM3—Signaling by GPCR—POMC—adrenal gland cancer	3.62e-05	0.000348	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—IGF1R—adrenal gland cancer	3.6e-05	0.000346	CbGpPWpGaD
Maprotiline—CHRM2—Signaling by GPCR—POMC—adrenal gland cancer	3.59e-05	0.000345	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—BAD—adrenal gland cancer	3.45e-05	0.000332	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—CDC42—adrenal gland cancer	3.41e-05	0.000327	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—POMC—adrenal gland cancer	3.37e-05	0.000324	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—CDC42—adrenal gland cancer	3.35e-05	0.000322	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—CDC42—adrenal gland cancer	3.35e-05	0.000322	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—CDC42—adrenal gland cancer	3.34e-05	0.000321	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—BRAF—adrenal gland cancer	3.33e-05	0.00032	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—CDC42—adrenal gland cancer	3.32e-05	0.000319	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—BAD—adrenal gland cancer	3.31e-05	0.000318	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—CDC42—adrenal gland cancer	3.29e-05	0.000316	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—IGF2—adrenal gland cancer	3.29e-05	0.000316	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—GNAS—adrenal gland cancer	3.26e-05	0.000313	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—MED12—adrenal gland cancer	3.26e-05	0.000313	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—IGF2—adrenal gland cancer	3.23e-05	0.000311	CbGpPWpGaD
Maprotiline—HTR7—Signaling by GPCR—EGFR—adrenal gland cancer	3.23e-05	0.00031	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—IGF2—adrenal gland cancer	3.23e-05	0.00031	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—IGF2—adrenal gland cancer	3.21e-05	0.000309	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—IGF2—adrenal gland cancer	3.2e-05	0.000308	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—GNAS—adrenal gland cancer	3.2e-05	0.000308	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—GNAS—adrenal gland cancer	3.2e-05	0.000307	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—GNAS—adrenal gland cancer	3.19e-05	0.000306	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—POMC—adrenal gland cancer	3.18e-05	0.000306	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—GNAS—adrenal gland cancer	3.18e-05	0.000305	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—IGF1R—adrenal gland cancer	3.18e-05	0.000305	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—IGF2—adrenal gland cancer	3.17e-05	0.000305	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—GNAS—adrenal gland cancer	3.15e-05	0.000302	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—BRAF—adrenal gland cancer	3.14e-05	0.000302	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—IGF1R—adrenal gland cancer	3.13e-05	0.0003	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—IGF1R—adrenal gland cancer	3.12e-05	0.0003	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—IGF1R—adrenal gland cancer	3.11e-05	0.000299	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—IGF1R—adrenal gland cancer	3.1e-05	0.000298	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—TERT—adrenal gland cancer	3.1e-05	0.000298	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—IGF1R—adrenal gland cancer	3.07e-05	0.000295	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—POMC—adrenal gland cancer	3.05e-05	0.000293	CbGpPWpGaD
Maprotiline—CHRM4—Signaling by GPCR—EGFR—adrenal gland cancer	3.05e-05	0.000293	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—BRAF—adrenal gland cancer	3.01e-05	0.000289	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—PRKACA—adrenal gland cancer	2.97e-05	0.000286	CbGpPWpGaD
Maprotiline—CHRM5—Signaling by GPCR—EGFR—adrenal gland cancer	2.92e-05	0.00028	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	2.91e-05	0.00028	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—PRKACA—adrenal gland cancer	2.8e-05	0.000269	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—TERT—adrenal gland cancer	2.73e-05	0.000263	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—BAD—adrenal gland cancer	2.7e-05	0.000259	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—TERT—adrenal gland cancer	2.69e-05	0.000259	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—TERT—adrenal gland cancer	2.68e-05	0.000258	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—TERT—adrenal gland cancer	2.68e-05	0.000257	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—TERT—adrenal gland cancer	2.67e-05	0.000256	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—TERT—adrenal gland cancer	2.64e-05	0.000254	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—POMC—adrenal gland cancer	2.56e-05	0.000246	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—POMC—adrenal gland cancer	2.48e-05	0.000239	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—BRAF—adrenal gland cancer	2.45e-05	0.000236	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—GNAS—adrenal gland cancer	2.41e-05	0.000232	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—CTNNB1—adrenal gland cancer	2.41e-05	0.000231	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—BAD—adrenal gland cancer	2.38e-05	0.000229	CbGpPWpGaD
Maprotiline—HTR2C—Signaling by GPCR—EGFR—adrenal gland cancer	2.38e-05	0.000229	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—PRKACA—adrenal gland cancer	2.37e-05	0.000228	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—BAD—adrenal gland cancer	2.34e-05	0.000225	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—BAD—adrenal gland cancer	2.34e-05	0.000224	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—BAD—adrenal gland cancer	2.33e-05	0.000224	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	2.32e-05	0.000223	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—BAD—adrenal gland cancer	2.32e-05	0.000223	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—BAD—adrenal gland cancer	2.3e-05	0.000221	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—GNAS—adrenal gland cancer	2.27e-05	0.000218	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—CTNNB1—adrenal gland cancer	2.27e-05	0.000218	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—ABCB1—adrenal gland cancer	2.23e-05	0.000214	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—POMC—adrenal gland cancer	2.19e-05	0.000211	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—CTNNB1—adrenal gland cancer	2.18e-05	0.000209	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—BRAF—adrenal gland cancer	2.17e-05	0.000208	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—POMC—adrenal gland cancer	2.16e-05	0.000207	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—POMC—adrenal gland cancer	2.15e-05	0.000207	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—POMC—adrenal gland cancer	2.15e-05	0.000206	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—POMC—adrenal gland cancer	2.14e-05	0.000206	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—BRAF—adrenal gland cancer	2.13e-05	0.000205	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—BRAF—adrenal gland cancer	2.13e-05	0.000204	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—BRAF—adrenal gland cancer	2.12e-05	0.000204	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—POMC—adrenal gland cancer	2.12e-05	0.000204	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—BRAF—adrenal gland cancer	2.11e-05	0.000203	CbGpPWpGaD
Maprotiline—DRD2—Signaling by GPCR—EGFR—adrenal gland cancer	2.1e-05	0.000202	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—BRAF—adrenal gland cancer	2.09e-05	0.000201	CbGpPWpGaD
Maprotiline—HTR2A—Signaling by GPCR—EGFR—adrenal gland cancer	2.07e-05	0.000198	CbGpPWpGaD
Maprotiline—HRH1—Signaling by GPCR—EGFR—adrenal gland cancer	2.06e-05	0.000198	CbGpPWpGaD
Maprotiline—CHRM1—Signaling by GPCR—EGFR—adrenal gland cancer	2.05e-05	0.000197	CbGpPWpGaD
Maprotiline—CHRM3—Signaling by GPCR—EGFR—adrenal gland cancer	2.05e-05	0.000197	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—PTGS2—adrenal gland cancer	2.04e-05	0.000196	CbGpPWpGaD
Maprotiline—CHRM2—Signaling by GPCR—EGFR—adrenal gland cancer	2.03e-05	0.000195	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—GNAS—adrenal gland cancer	1.92e-05	0.000185	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—EGFR—adrenal gland cancer	1.91e-05	0.000183	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—ABCB1—adrenal gland cancer	1.89e-05	0.000181	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—EGFR—adrenal gland cancer	1.8e-05	0.000173	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—CTNNB1—adrenal gland cancer	1.77e-05	0.00017	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—EGFR—adrenal gland cancer	1.72e-05	0.000166	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—POMC—adrenal gland cancer	1.62e-05	0.000156	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—TP53—adrenal gland cancer	1.6e-05	0.000154	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—CTNNB1—adrenal gland cancer	1.56e-05	0.00015	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—CTNNB1—adrenal gland cancer	1.54e-05	0.000148	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—CTNNB1—adrenal gland cancer	1.54e-05	0.000148	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—CTNNB1—adrenal gland cancer	1.53e-05	0.000147	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—POMC—adrenal gland cancer	1.53e-05	0.000147	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—CTNNB1—adrenal gland cancer	1.53e-05	0.000147	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—CTNNB1—adrenal gland cancer	1.51e-05	0.000145	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—TP53—adrenal gland cancer	1.51e-05	0.000145	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—TP53—adrenal gland cancer	1.45e-05	0.000139	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—EGFR—adrenal gland cancer	1.4e-05	0.000135	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—POMC—adrenal gland cancer	1.3e-05	0.000125	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—PTGS2—adrenal gland cancer	1.29e-05	0.000124	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—EGFR—adrenal gland cancer	1.24e-05	0.000119	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—PTGS2—adrenal gland cancer	1.22e-05	0.000117	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—EGFR—adrenal gland cancer	1.22e-05	0.000117	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—EGFR—adrenal gland cancer	1.22e-05	0.000117	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—EGFR—adrenal gland cancer	1.21e-05	0.000117	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—EGFR—adrenal gland cancer	1.21e-05	0.000116	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—EGFR—adrenal gland cancer	1.2e-05	0.000115	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—TP53—adrenal gland cancer	1.18e-05	0.000113	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—TP53—adrenal gland cancer	1.04e-05	0.0001	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—PTGS2—adrenal gland cancer	1.03e-05	9.93e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—TP53—adrenal gland cancer	1.02e-05	9.84e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—TP53—adrenal gland cancer	1.02e-05	9.82e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—TP53—adrenal gland cancer	1.02e-05	9.79e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—TP53—adrenal gland cancer	1.02e-05	9.76e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—TP53—adrenal gland cancer	1.01e-05	9.66e-05	CbGpPWpGaD
